VC  Bay City Capital

     Office Locations:

750 Battery Street, Suite 400
San Francisco, CA 94111
Phone: 415-676-3830
Fax: 415-837-0503



  • Early
  • Seed



  • Food & Agriculture
  • Life Sciences & Healthcare



    Bay City Capital was established in 1997 as an equal partnership between The Craves Group, LLC and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry and related activities. Since that date, the firm has managed five investment funds representing $1.3 billion in committed capital and invested in over 90 companies. Five of these funds are general life sciences funds and three are sector funds. In addition, Bay City serves as the investment advisor for The North American Nutrition and Agribusiness Fund, LP (NANAF), a sector fund, representing $111 million in committed capital. Bay City Capital seeks to maintain a balanced and diversified portfolio across the various life sciences sectors and with companies at various stages of development.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Andrew Han Analyst
    Carl Goldfischer MD Managing Director
    David Beier JD Managing Director
    Dayton Misfeldt Managing Director
    Fred Craves PhD Managing Director


    Recent Funding Events (trailing 12 months):










      Series B


    Portfolio companies include:

        web link

      Cadence Pharmaceuticals
        web link

      Civitas Therapeutics
        web link

      Conatus Pharmaceuticals
        web link

        web link

        web link

        web link

        web link

      Fabric Genomics
        web link

      Hyperion Therapeutics
        web link

      Idev Technologies
        web link

        web link

      Interleukin Genetics
        web link

      Iterum Therapeutics
        web link

      Kezar Life Sciences
        web link

      Madrigal Pharmaceuticals
        web link

        web link


      PharmAkea Therapeutics
        web link

      Presidio Pharmaceuticals
        web link

      PTC Therapeutics
        web link

      Reset Therapeutics
        web link

        web link

        web link

      Twist Bioscience
        web link

      Vivaldi Biosciences
        web link

        web link

      Xeris Pharmaceuticals
        web link


    Recent News: